Regulatory
The Environment for Homeopathy in Canada
By David Skinner, Association Manager, Canadian Homeopathic Pharmaceutical Association In the global context, Canada is a very small market, but the dynamics are no different than in other large markets…
Read More117th Congress and Biden Administration Underway
By Pete Evich, AAHP Government Affairs On Jan. 20, Joe Biden was sworn in as the 46th President of the United States. On the same day, both of Georgia’s…
Read More2020 Presidential & Congressional Elections: Outcome and Agenda Outlook in the 117th Congress
By Pete Evich, AAHP Regulatory Affairs Presidency and Congress President-elect Joe Biden managed to defeat an incumbent president — the first time that’s happened in 28 years. Sen. Kamala…
Read MoreHow Real-World Data Is Impacting Health Care Decisions Today
By Mark Land, AAHP President I have been interested in the application of Real-World Data (RWD) and Real-World Evidence (RWE) for some time now. Originally, I confused RWD and RWE…
Read MoreHomeopathic Process Validation for Beginners
Consistent, effective, high-quality homeopathic products. That’s what our consumers want in each and every dose. Yet quality doesn’t happen by accident. Manufacturers must create it through process validation. Each manufacturer…
Read MoreCOVID-19 CARES Act Aids Availability of OTC Products
On March 27, President Trump signed into law the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). This landmark legislation provides financial relief for workers, small businesses, and healthcare professionals affected by the coronavirus…
Read MoreHomeopathy Mentioned Twice in FDA 2021 Budget Is Telling of Issues to Come
By Mark Land, AAHP President | In February, the White House released the President’s Fiscal Year 2021 Budget. Correspondingly, each agency publishes a detailed budget justification…
Read MoreIn Times of Public Health Crisis, Vulnerable Consumers Look to Us for Sound Advice
By Mark Land, AAHP President | I have experienced many infectious disease crises thus far in my lifetime and each one was characterized by fear and uncertainty…
Read MoreAAHP 2019: Reawakening the Regulatory and Retail Dialog
By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality. AAHP has been there for…
Read MoreTrump Nominates New FDA Commissioner
Senate Hearing Set for Nov. 20 By Pete Evich, AAHP Govt. Relations On Nov. 1, President Trump nominated Stephen Hahn, chief medical executive of the MD Anderson Cancer Center…
Read More